image

Figure S12 from CD38 x ICAM-1 Bispecific Antibody Is a Novel Approach for Treating Multiple Myeloma and Lymphoma

Authors
Publication date
1 February 2024
Publisher
Doi

    Abstract

    ICAM-1 and CD38 expression after TNFa treatment</p

      Similar works

      Full text

      thumbnail-image

      Available Versions

      The Francis Crick Institute

      redirect
      oaioai:figshare.com:article/25125...
      Last time updated on 06/02/2024